Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephritis, Hereditary | 3 | 2022 | 21 | 1.990 |
Why?
|
| Kidney | 9 | 2023 | 1346 | 1.320 |
Why?
|
| Urogenital Abnormalities | 3 | 2023 | 168 | 1.190 |
Why?
|
| Kidney Diseases | 3 | 2024 | 479 | 1.070 |
Why?
|
| Urinary Tract | 3 | 2023 | 60 | 1.050 |
Why?
|
| Intellectual Disability | 7 | 2024 | 1043 | 1.030 |
Why?
|
| Hematuria | 2 | 2022 | 50 | 0.830 |
Why?
|
| Mitochondrial Diseases | 2 | 2024 | 135 | 0.790 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2019 | 40 | 0.670 |
Why?
|
| Mutation | 11 | 2022 | 5794 | 0.660 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 245 | 0.610 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 213 | 0.610 |
Why?
|
| Collagen Type IV | 2 | 2022 | 20 | 0.560 |
Why?
|
| Phenotype | 12 | 2024 | 4220 | 0.540 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2016 | 79 | 0.520 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 658 | 0.490 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2024 | 469 | 0.420 |
Why?
|
| Microcephaly | 3 | 2024 | 328 | 0.400 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 80 | 0.390 |
Why?
|
| Child | 20 | 2024 | 24168 | 0.380 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2019 | 3083 | 0.380 |
Why?
|
| Genetic Testing | 5 | 2024 | 995 | 0.380 |
Why?
|
| Muscle Weakness | 1 | 2012 | 82 | 0.380 |
Why?
|
| Muscular Atrophy | 1 | 2012 | 75 | 0.380 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 942 | 0.370 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 101 | 0.370 |
Why?
|
| Cataract | 1 | 2012 | 218 | 0.330 |
Why?
|
| Ovary | 1 | 2012 | 390 | 0.320 |
Why?
|
| Pedigree | 4 | 2022 | 1580 | 0.310 |
Why?
|
| Exome | 4 | 2019 | 1042 | 0.300 |
Why?
|
| Bone Density | 3 | 2007 | 307 | 0.300 |
Why?
|
| beta-Thalassemia | 2 | 2007 | 28 | 0.300 |
Why?
|
| Humans | 38 | 2024 | 122853 | 0.300 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 3 | 2010 | 16 | 0.290 |
Why?
|
| Genotype | 3 | 2022 | 2536 | 0.270 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2024 | 553 | 0.270 |
Why?
|
| Adolescent | 12 | 2021 | 19037 | 0.260 |
Why?
|
| Cardiac Output, Low | 1 | 2006 | 66 | 0.260 |
Why?
|
| Female | 23 | 2022 | 65278 | 0.240 |
Why?
|
| Edema | 1 | 2006 | 133 | 0.240 |
Why?
|
| Epilepsy | 2 | 2023 | 859 | 0.230 |
Why?
|
| Arginine-tRNA Ligase | 1 | 2024 | 9 | 0.230 |
Why?
|
| Male | 22 | 2024 | 59866 | 0.220 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2024 | 446 | 0.220 |
Why?
|
| Kidney Failure, Chronic | 3 | 2019 | 866 | 0.220 |
Why?
|
| Zinc | 1 | 2004 | 128 | 0.220 |
Why?
|
| Age of Onset | 4 | 2012 | 581 | 0.210 |
Why?
|
| Seizures | 3 | 2024 | 875 | 0.200 |
Why?
|
| Child, Preschool | 10 | 2021 | 13858 | 0.200 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2022 | 32 | 0.200 |
Why?
|
| Autoantigens | 1 | 2022 | 133 | 0.190 |
Why?
|
| Mutation, Missense | 3 | 2023 | 846 | 0.190 |
Why?
|
| Haploinsufficiency | 2 | 2021 | 248 | 0.190 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2024 | 81 | 0.190 |
Why?
|
| Nephrectomy | 1 | 2022 | 173 | 0.190 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2021 | 23 | 0.190 |
Why?
|
| Purpura | 1 | 2021 | 24 | 0.190 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2021 | 18 | 0.180 |
Why?
|
| Genes, Recessive | 2 | 2019 | 172 | 0.180 |
Why?
|
| Young Adult | 5 | 2021 | 8826 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2021 | 118 | 0.180 |
Why?
|
| Spectrin | 1 | 2021 | 64 | 0.180 |
Why?
|
| Caribbean Region | 1 | 2019 | 15 | 0.170 |
Why?
|
| Nephrons | 1 | 2019 | 20 | 0.170 |
Why?
|
| beta Catenin | 1 | 2020 | 209 | 0.170 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 87 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 1760 | 0.160 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 6 | 0.160 |
Why?
|
| Xenopus laevis | 1 | 2019 | 122 | 0.160 |
Why?
|
| Kidney Transplantation | 1 | 2024 | 629 | 0.160 |
Why?
|
| Leigh Disease | 1 | 2019 | 25 | 0.160 |
Why?
|
| RNA Helicases | 1 | 2019 | 63 | 0.160 |
Why?
|
| Biopsy | 1 | 2022 | 1256 | 0.160 |
Why?
|
| Infant | 9 | 2021 | 12355 | 0.160 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 118 | 0.150 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 997 | 0.150 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 695 | 0.150 |
Why?
|
| Drosophila Proteins | 1 | 2024 | 709 | 0.150 |
Why?
|
| Homozygote | 1 | 2019 | 535 | 0.150 |
Why?
|
| Denys-Drash Syndrome | 1 | 2017 | 4 | 0.150 |
Why?
|
| Autistic Disorder | 1 | 2021 | 345 | 0.150 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 639 | 0.150 |
Why?
|
| WT1 Proteins | 1 | 2017 | 27 | 0.140 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2017 | 36 | 0.140 |
Why?
|
| Exons | 1 | 2019 | 795 | 0.140 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 30 | 0.140 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2019 | 469 | 0.140 |
Why?
|
| Muscle Hypotonia | 3 | 2024 | 186 | 0.130 |
Why?
|
| Adult | 10 | 2024 | 28926 | 0.130 |
Why?
|
| Microfilament Proteins | 2 | 2021 | 278 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 677 | 0.120 |
Why?
|
| Osteoporosis | 2 | 2007 | 114 | 0.120 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 371 | 0.110 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 149 | 0.110 |
Why?
|
| Stroke | 1 | 2021 | 957 | 0.110 |
Why?
|
| DNA Polymerase gamma | 1 | 2012 | 10 | 0.100 |
Why?
|
| Glutarates | 1 | 2012 | 27 | 0.100 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 28 | 0.100 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 758 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2016 | 815 | 0.100 |
Why?
|
| Smad4 Protein | 1 | 2011 | 57 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2021 | 2589 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 159 | 0.090 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2010 | 33 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1283 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2583 | 0.090 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 796 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3479 | 0.080 |
Why?
|
| Brain | 1 | 2021 | 2961 | 0.080 |
Why?
|
| Mitral Valve | 1 | 2011 | 247 | 0.080 |
Why?
|
| Glycine | 1 | 2010 | 167 | 0.080 |
Why?
|
| Hearing Loss | 1 | 2010 | 132 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4308 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2012 | 1069 | 0.080 |
Why?
|
| Aorta | 1 | 2011 | 540 | 0.070 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2007 | 55 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2022 | 15927 | 0.070 |
Why?
|
| Heterozygote | 2 | 2021 | 682 | 0.070 |
Why?
|
| Albuminuria | 1 | 2006 | 91 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 59 | 0.070 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2006 | 52 | 0.070 |
Why?
|
| Animals | 3 | 2024 | 33923 | 0.060 |
Why?
|
| Universal Precautions | 1 | 2004 | 4 | 0.060 |
Why?
|
| Sodium | 1 | 2006 | 290 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1634 | 0.060 |
Why?
|
| Centrioles | 1 | 2023 | 13 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1881 | 0.060 |
Why?
|
| Disease Transmission, Infectious | 1 | 2004 | 85 | 0.060 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2011 | 653 | 0.050 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2023 | 18 | 0.050 |
Why?
|
| Genetic Counseling | 1 | 2024 | 222 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 317 | 0.050 |
Why?
|
| Integrins | 1 | 2023 | 81 | 0.050 |
Why?
|
| Mutant Proteins | 1 | 2023 | 112 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2006 | 1317 | 0.050 |
Why?
|
| Blood Transfusion | 1 | 2004 | 302 | 0.050 |
Why?
|
| Dogs | 1 | 2023 | 770 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2006 | 767 | 0.050 |
Why?
|
| Iran | 3 | 2007 | 63 | 0.050 |
Why?
|
| Collagen Type V | 1 | 2021 | 4 | 0.050 |
Why?
|
| Cross Infection | 1 | 2004 | 332 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2023 | 619 | 0.050 |
Why?
|
| Collagen Type III | 1 | 2021 | 21 | 0.050 |
Why?
|
| Time | 1 | 2021 | 92 | 0.050 |
Why?
|
| Problem Behavior | 1 | 2021 | 37 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2004 | 368 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 2010 | 5017 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 68 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 143 | 0.040 |
Why?
|
| Dwarfism | 1 | 2021 | 102 | 0.040 |
Why?
|
| Face | 1 | 2021 | 181 | 0.040 |
Why?
|
| Drosophila | 1 | 2024 | 766 | 0.040 |
Why?
|
| Alleles | 1 | 2024 | 1599 | 0.040 |
Why?
|
| Calcium | 1 | 2004 | 1097 | 0.040 |
Why?
|
| Proteins | 1 | 2023 | 1045 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2004 | 842 | 0.040 |
Why?
|
| Retina | 1 | 2020 | 458 | 0.040 |
Why?
|
| Pleckstrin Homology Domains | 1 | 2016 | 1 | 0.040 |
Why?
|
| Gestational Age | 1 | 2021 | 1119 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 1216 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2021 | 860 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 429 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2016 | 175 | 0.030 |
Why?
|
| Hypertension, Renal | 1 | 2005 | 37 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2021 | 1024 | 0.030 |
Why?
|
| Urine | 1 | 2005 | 88 | 0.030 |
Why?
|
| Proteinuria | 1 | 2005 | 110 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 513 | 0.030 |
Why?
|
| United States | 1 | 2010 | 10538 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 1834 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2019 | 8120 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 3641 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2014 | 124 | 0.030 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 59 | 0.030 |
Why?
|
| Pregnancy | 1 | 2006 | 7126 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2013 | 245 | 0.030 |
Why?
|
| Fibrillins | 1 | 2011 | 31 | 0.020 |
Why?
|
| Fibrillin-1 | 1 | 2011 | 58 | 0.020 |
Why?
|
| Genotyping Techniques | 1 | 2011 | 101 | 0.020 |
Why?
|
| Intestinal Polyposis | 1 | 2011 | 17 | 0.020 |
Why?
|
| Fetus | 1 | 2014 | 579 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2014 | 527 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 306 | 0.020 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2011 | 70 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2011 | 336 | 0.020 |
Why?
|
| Mass Screening | 1 | 2005 | 786 | 0.020 |
Why?
|
| Marfan Syndrome | 1 | 2011 | 137 | 0.020 |
Why?
|
| Disease Progression | 1 | 2005 | 1996 | 0.020 |
Why?
|
| Trinucleotide Repeats | 1 | 2008 | 109 | 0.020 |
Why?
|
| Genomics | 1 | 2014 | 1472 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2008 | 230 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 1290 | 0.020 |
Why?
|
| Middle Aged | 4 | 2008 | 25798 | 0.020 |
Why?
|
| DNA | 1 | 2011 | 1608 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 17647 | 0.020 |
Why?
|
| Obesity | 1 | 2016 | 2089 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2007 | 180 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 945 | 0.020 |
Why?
|
| Creatinine | 1 | 2006 | 379 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 3245 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 1300 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2008 | 1473 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 1242 | 0.010 |
Why?
|
| Survivors | 1 | 2006 | 346 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2004 | 171 | 0.010 |
Why?
|
| Aged | 3 | 2008 | 18917 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 2796 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 9928 | 0.010 |
Why?
|
| Prevalence | 1 | 2007 | 2384 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 4673 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 1468 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 1407 | 0.010 |
Why?
|
| Hypertension | 1 | 2006 | 1275 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2004 | 5996 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 6325 | 0.010 |
Why?
|